Lotus Eye Hospital and Institute DuPont analysis

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	0.66×	−1.50×	0.53×	0.73×	0.72×
	0.79×	0.15×	3.24×	1.43×	1.23×
	0.5%	−0.7%	0.9%	5.8%	9.8%
	0.71×	0.71×	0.73×	0.74×	0.74×
	1.37×	1.37×	1.16×	1.12×	1.10×
	0.3%	0.1%	1.3%	5.0%	7.0%
	0.1%	0.1%	1.2%	5.0%	7.1%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

LOTUSEYE₹112.75

Lotus Eye Hospital and Institute Limited

· Pharma & Health

₹ CrorePeersGPTHEALTH GKSL SHALBY INDRAMEDCO ARTEMISMED DRAGARWQ KMCSHIL KOVAIMcap ₹234 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	0.72	0.73	0.53	-1.50	0.66
Interest Burden (Pretax/EBIT) ×	1.23	1.43	3.24	0.15	0.79
EBIT Margin %	9.79	5.81	0.86	-0.68	0.50
Asset Turnover ×	0.74	0.74	0.73	0.71	0.71
Financial Leverage (Assets/Equity) ×	1.10	1.12	1.16	1.37	1.37
ROE (5-step product, year-end total equity) %	7.04	5.02	1.26	0.15	0.25
ROE (owners' profit / average owners' equity) %	7.08	4.98	1.24	0.13	0.13

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.